Altomari Alfred Insider Trades

Insider Trading History

Track insider trading activity for Altomari Alfred. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $29.6k 19,624 shares
Last Trade
Aug 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$72.6k 47,749 shares
$1.52
$1.51
Insmed
Insmed INSM
Director
Holding Value $7.22M 69,495 shares
Last Trade
May 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340k 13,162 shares
$25.83
$103.86
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $72.1k 47,749 shares
Last Trade
Jun 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 12,500 shares
$2.48
$1.51
Insmed
Insmed INSM
Director
Holding Value $5.85M 56,333 shares
Last Trade
May 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 13,192 shares
$18.95
$103.86
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $45.3k 30,000 shares
Last Trade
Nov 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.3M 30,000 shares
$510.75
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $97.2k 64,343 shares
Last Trade
Aug 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$53.6M 50,000 shares
$1,072.75
$1.51
Insmed
Insmed INSM
Director
Holding Value $4.48M 43,141 shares
Last Trade
May 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 14,645 shares
$17.07
$103.86
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $1.02M 675,000 shares
Last Trade
Jan 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.1B 675,000 shares
$34,200.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $866k 573,734 shares
Last Trade
Oct 13, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.98B 88,236 shares
$79,070.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $778k 514,910 shares
Last Trade
Jul 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.17B 26,200 shares
$121,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $738k 488,710 shares
Last Trade
May 18, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.18B 20,000 shares
$159,000.00
$1.51
Insmed
Insmed INSM
Director
Holding Value $2.96M 28,496 shares
Last Trade
May 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 7,558 shares
$26.46
$103.86
Baudax Bio
Baudax Bio BXRX
Director
Holding Value $2.57k 117,785 shares
Last Trade
Apr 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98M 56,452 shares
$1,736.00
$0.02
Baudax Bio
Baudax Bio BXRX
Director
Holding Value $1.82k 83,333 shares
Last Trade
Apr 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$145M 83,333 shares
$1,736.00
$0.02
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $708k 468,710 shares
Last Trade
Mar 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.35B 12,500 shares
$188,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $1.05M 692,641 shares
Last Trade
Jan 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195B 692,641 shares
$282,000.00
$1.51
Insmed
Insmed INSM
Director
Holding Value $2.17M 20,938 shares
Last Trade
Dec 07, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$791k 20,000 shares
$39.57
$103.86
Baudax Bio
Baudax Bio BXRX
Director
Holding Value $1.34k 61,333 shares
Last Trade
Nov 23, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.35M 5,000 shares
$1,470.00
$0.02
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Aug 20, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.8B 94,599 shares
$294,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Executive Officer
Holding Value $689k 456,210 shares
Last Trade
Aug 20, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.8B 94,599 shares
$294,000.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up